Journal article
Hereditary amyloidosis with progressive peripheral neuropathy associated with apolipoprotein Al Gly26Arg: Outcome of hepatorenal transplantation
Adam G Testro, Stephen O Brennan, Richard AL Macdonell, Philip N Hawkins, Peter W Angus
LIVER TRANSPLANTATION | JOHN WILEY & SONS INC | Published : 2007
DOI: 10.1002/lt.21176
Abstract
Liver transplantation (LT) has been reported in only 1 patient with hereditary variant apolipoprotein AI (apoAI) amyloidosis and was associated with a 50% decrease in production of variant apoAI. The potential for this to benefit clinical manifestations of apoAI amyloidosis such as peripheral neuropathy has not been determined. A 59-yr-old Irish-born male with hereditary systemic amyloidosis associated with apoAI Gly26Arg, which was suspected to be the cause of a progressive peripheral neuropathy, along with end-stage renal failure and hepatic dysfunction, underwent hepatorenal transplantation. Evaluation of his clinical outcome included serial neurological examinations and nerve conduction ..
View full abstractGrants
Awarded by Medical Research Council
Awarded by MRC